Neuromodulation vs. Electrolysis in Plantar Fasciitis

Not Applicable

Completed

• Conditions: Plantar Fascitis
• Interventions: Other: Percutaneous neuromodulation in tibial nerve; Other: Percutaneous electrolysis

• Registration Number: NCT05826301
• Lead Sponsor: Universidad Europea de Madrid

Brief Summary

The aim of the present study will be the implementation of two protocols in plantar fasciitis individuals: a) percutaneous neuromodulation, b) percutaneous electrolysis in plantar fascia. Authors hypothesized that percutaneous neuromodulation may have benefits in: pain, quality of life, muscular structure.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-01
• Primary Completion: 2022-09-30
• Study First Submitted: 2023-02-21
• Status Verified: 2023-04
• Study First Submitted QC: 2023-04-20
• Study First Posted: 2023-04-24
• Study Completion: 2023-08-15
• Last Update Submitted: 2023-10-25
• Last Update Posted: 2023-10-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 67

Inclusion Criteria

• Patiens with plantar fasciitis

Exclusion Criteria

• Lower limb disturbances
• Sistemic diseases
• Not involved in other drug or manual therapy interventions
• Infections

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Percutaneous neuromodulation in tibial nerve	Percutaneous neuromodulation in tibial nerve	Specifically, the procedure consisted in the application of a square wave biphasic electrical current, with 2-4 Hz frequency, 450 μs pulse during 25 minutes with a needle (0.30mm x 40 mm) inserted proximal to the surface on the tibial nerve. 2 times per week
Percutaneous electrolysis	Percutaneous electrolysis	The procedure consist on placed a needle (0.30mm x 40 mm) on the most hyperalgesic plantar fascia location with a galvanic current of 3mA, 3 times during 3 seconds. 1 time per week

Primary Outcome Measures

Name	Time	Method
Pain intensity	at 4 weeks	visual analogue scale (VAS)

Secondary Outcome Measures

Name	Time	Method
Ultrasonography of extrinsic foot muscles	at 4 weeks	Ultrasound imaging of the thickness and cross-sectional area of the tibiais
quality of life perception	at 4 weeks	SF-36 questionnaire

Trial Locations

Locations (2)

Universidad Europea; 🇪🇸 Madrid, Spain

UEM; 🇪🇸 Madrid, Spain